@article{article, title  = {{Molnupiravir versus placebo in unvaccinated and vaccinated patients with early SARS-CoV-2 infection in the UK (AGILE CST-2): a randomised, placebo-controlled, double-blind, phase 2 trial}},

 publisher = {{Elsevier BV}},

 url = {{}},

 year = {{2022}},

 month = {{11}},

 author = {{Khoo SH and FitzGerald R and Saunders G and Middleton C and Ahmad S and Edwards CJ and Hadjiyiannakis D and Walker L and Lyon R and Shaw V and Mozgunov P et al}},

 doi = {{10.1016/s1473-3099(22)00644-2}},

 journal = {{The Lancet Infectious Diseases}},

 note = {{Accessed on 2024/10/19}}}